Emerging Infectious Disease ISSN: 1080-6059

Assessing the Costs and Benefits of an Oral Vaccine for Raccoon Rabies: A Possible Model

Martin I. Meltzer

Author affiliation: Centers for Disease Control and Prevention, Atlanta, Georgia, USA

Figure 2

Threshold price for the oral vaccine at different levels of bait density and three distribution costs:cost-savings ratios for the expanding circles scenario Notes: Threshold price occurs at the point that the net present value of a vaccination program = $0. The distribution costs:cost-savings ratios are calculated on a per unit area basis, using the maximum cost-savings figures (i.e., savings resulting from avoiding an epizootic).

Figure 2. Threshold price for the oral vaccine at different levels of bait density and three distribution costs:cost-savings ratios for the expanding circles scenario Notes: Threshold price occurs at the point that the net present value of a vaccination program = $0. The distribution costs:cost-savings ratios are calculated on a per unit area basis, using the maximum cost-savings figures (i.e., savings resulting from avoiding an epizootic).

Main Article

Top of Page

The opinions expressed by authors contributing to this journal do not necessarily reflect the opinions of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.